153 related articles for article (PubMed ID: 37947608)
21. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract][Full Text] [Related]
22. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
23. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
24. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
25. OCT-4 and DAZL expression in precancerous lesions of the human uterine cervix.
Stefanidis K; Pergialiotis V; Christakis D; Patta J; Stefanidi D; Loutradis D
J Obstet Gynaecol Res; 2015 May; 41(5):763-7. PubMed ID: 25491317
[TBL] [Abstract][Full Text] [Related]
26. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.
Li BH; Zhou JS; Ye F; Cheng XD; Zhou CY; Lu WG; Xie X
Eur J Cancer; 2011 Sep; 47(14):2166-74. PubMed ID: 21636267
[TBL] [Abstract][Full Text] [Related]
27. IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.
DeCarlo CA; Severini A; Edler L; Escott NG; Lambert PF; Ulanova M; Zehbe I
Lab Invest; 2010 Oct; 90(10):1482-91. PubMed ID: 20479716
[TBL] [Abstract][Full Text] [Related]
28. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
29. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.
Kwasniewska A; Postawski K; Gozdzicka-Jozefiak A; Kwasniewski W; Grywalska E; Zdunek M; Korobowicz E
Oncol Rep; 2011 Jul; 26(1):153-60. PubMed ID: 21491087
[TBL] [Abstract][Full Text] [Related]
30. [Correlation between Methylation of SALL3 and Cervical Cancer].
Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
[TBL] [Abstract][Full Text] [Related]
31. Expression and significance of SHP-2 in human papillomavirus infected cervical cancer.
Meng F; Zhao X; Zhang S
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):247-251. PubMed ID: 22528229
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
33. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix.
Farnsworth A; Laverty C; Stoler MH
Int J Gynecol Pathol; 1989; 8(4):321-30. PubMed ID: 2553629
[TBL] [Abstract][Full Text] [Related]
35. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
[TBL] [Abstract][Full Text] [Related]
36. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.
Ahmad A; Raish M; Shahid M; Batra S; Batra V; Husain SA
Cancer Biomark; 2017 Jul; 19(4):375-381. PubMed ID: 28453456
[TBL] [Abstract][Full Text] [Related]
37. Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study.
Flatley JE; Sargent A; Kitchener HC; Russell JM; Powers HJ
BMC Cancer; 2014 Nov; 14():803. PubMed ID: 25367268
[TBL] [Abstract][Full Text] [Related]
38. Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.
Wang L; Li H; Liang F; Hong Y; Jiang S; Xiao L
Med Oncol; 2014 Sep; 31(9):143. PubMed ID: 25106529
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of HOXB2 and HOXB13 proteins is associated with HPV infection and cervical cancer progression.
Gonzalez-Herrera A; Salgado-Bernabe M; Velazquez-Velazquez C; Salcedo-Vargas M; Andrade-Manzano A; Avila-Moreno F; Pina-Sanchez P
Asian Pac J Cancer Prev; 2015; 16(4):1349-53. PubMed ID: 25743797
[TBL] [Abstract][Full Text] [Related]
40. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
